Tezepelumab shows positive results in reducing size of nasal polyps

Professor Lipworth. Credit: Sheanne Mulholland/University of Dundee

By Ryan McDougall, PA Media

An asthma drug has shown positive results when used to treat nasal polyps, researchers have said.

Tezepelumab was first approved for treating asthma in 2021, but new research led by a University of Dundee professor has found it also reduces the size of nasal polyps and nasal blockages.